PUBLICATIONS · 37863088
Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2023 Nov
- First author
- Pan J
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2023 Nov;24(11):1163-1164. doi: 10.1016/S1470-2045(23)00517-X.
- note
- Source null
- related pmid
- 37863087
- relationship
- Comment in
Authors and identifiers
- name
- Pan J
- type
- Author
- name
- Tang K
- type
- Author
- name
- Luo Y
- type
- Author
- name
- Seery S
- type
- Author
- name
- Tan Y
- type
- Author
- name
- Deng B
- type
- Author
- name
- Liu F
- type
- Author
- name
- Xu X
- type
- Author
- name
- Ling Z
- type
- Author
- name
- Song W
- type
- Author
- name
- Xu J
- type
- Author
- name
- Duan J
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Pan J
- type
- Author
- name
- Tang K
- type
- Author
- name
- Luo Y
- type
- Author
- name
- Seery S
- type
- Author
- name
- Tan Y
- type
- Author
- name
- Deng B
- type
- Author
- name
- Liu F
- type
- Author
- name
- Xu X
- type
- Author
- name
- Ling Z
- type
- Author
- name
- Song W
- type
- Author
- name
- Xu J
- type
- Author
- name
- Duan J
- type
- Author
- bibliography ids
- nci-bib-e39645642ad2686d12940f38
- book metadata
- content sha256
- e400525f5e4ebd8ae571d4e2f89d6ffea294073c27bdb33dfd2fd96d8fbc103a
- document type
- citation
- dois
- 10.1016/S1470-2045(23)00436-9
- electronic publication date
- display
- 2023 Oct 17
- precision
- day
- year
- 2023
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:37863088
- immutable id
- pubmed:37863088@e400525f5e4ebd8ae571d4e2f89d6ffea294073c27bdb33dfd2fd96d8fbc103a
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 11
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1229-1241
- volume
- 24
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Lancet Oncol. 2023 Nov;24(11):1163-1164. doi: 10.1016/S1470-2045(23)00517-X.
- note
- Source null
- related pmid
- 37863087
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 37863088
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- 650bd13d297be3ee00bc084c21d1c91ebce271b562fa78f2c2e700cea2c93a3c
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2023 Nov
- precision
- month
- year
- 2023
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Sequential CD19 and CD22 chimeric antigen receptor T-cell therapy for childhood refractory or relapsed B-cell acute lymphocytic leukaemia: a single-arm, phase 2 study.
Preserved source evidence · Not medical advice
Triangle